Immunotherapy vs Antihistamines: The Whole-Category Comparison

They are not directly interchangeable because they do different jobs, and this holds across every form of each. Antihistamines, whether oral pills, nasal sprays, or eye drops, are excellent for fast, temporary relief of mild or occasional symptoms, and they require no testing or long-term commitment. Immunotherapy, whether drops, tablets, or shots, works to reduce the underlying allergic sensitivity over a multi-year course, which may lead to lasting relief that continues after treatment ends. For people with persistent symptoms who are tired of medicating every day, immunotherapy can offer longer-term value, but it requires diagnosis, commitment, and patience. Many allergists recommend antihistamines for breakthrough symptoms while immunotherapy builds. The right choice depends on symptom severity, how long they last each year, and personal preference.

There are three main routes, and they all retrain immune tolerance rather than masking symptoms. Sublingual immunotherapy as liquid allergy drops is held under the tongue daily at home; in the United States these drops are not FDA-approved and are used off-label. Sublingual immunotherapy as tablets, such as Grastek, Oralair, Ragwitek, and Odactra, is FDA-approved but available only for a few single allergens like grass, ragweed, and dust mite. Allergy shots, or subcutaneous immunotherapy, are injected and given in a clinic, with a long track record across many allergens. All three work over a similar multi-year timeline, and the best route depends on your allergens, lifestyle, and tolerance for clinic visits, which an allergist can help you weigh.

In most cases yes, and many patients do, especially during the early months before immunotherapy has had time to work. Antihistamines can help manage breakthrough symptoms and may even reduce certain mild local reactions to immunotherapy. However, you should always confirm with your prescribing allergist, because some protocols ask you to note or temporarily hold antihistamines around specific doses so reactions can be observed accurately. This applies whether your immunotherapy is drops, tablets, or shots. Never start, stop, or change any medication on your own while undergoing immunotherapy. Your care team can advise how to combine the two safely so you get symptom relief now while the immunotherapy works toward longer-term change in your allergic response.

True pharmacologic tolerance to antihistamines is uncommon, but many people feel like their pills work less well over the years. This usually reflects worsening or broadening allergies rather than the drug failing. Because antihistamines only block histamine and do not change the underlying allergy, increasing exposure or new sensitivities can outpace what a pill, spray, or eye drop can mask. This is one reason people look into immunotherapy: rather than escalating symptom-blocking medication, immunotherapy works to reduce the immune system's reactivity itself. If your usual antihistamine seems less effective, it is worth discussing allergy testing with a clinician to understand what is driving the change and whether a disease-modifying route makes sense.

For chronic or seasonal allergies, antihistamines are typically taken every day during exposure for as long as symptoms persist, which for many people means months each year or indefinitely. They do not alter the underlying allergy, so there is no built-in endpoint. Immunotherapy of any route is structured differently: it is a time-limited course, commonly around three to five years, after which many patients maintain relief without ongoing treatment. That contrast in timeline is central to the decision. If the idea of taking a pill every day for the foreseeable future is unappealing, a disease-modifying option, whether drops, tablets, or shots, may be worth exploring with an allergist who can match the route to your situation.